AKT1 and Hepatic fibrosis: The upregulated expression of miR23a-5p activates the PI3K/AKT/mTOR/Snail pathway to activate hepatic stellate cells and induce hepatic fibrosis, providing new therapeutic targets for the treatment of liver fibrosis [162].